Featured post
SCS research and awards news
For all our research and awards news, please visit our news page.
Thursday, 14 May 2015
Fixed-dose combination therapy with daclatasvir, asunaprevir, and beclabuvir for noncirrhotic patients with HCV genotype 1 infection.
Professor Sievert
William Sievert published in
JAMA
.
Read article
here
.
No comments:
Post a Comment
Newer Post
Older Post
Home
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment